Please take special note
Several days ago, I wrote that the manufacturer of Zevalin has ceased marketing and promotion of the medication. I did not say that production was halted. This is a most important distinction.
A few blog readers have assumed, based upon my above statement, that Zevalin is no longer available. This is not the case.
However, Betsy and I have declared on numerous occasions that radioimmunotherapy (Zevalin and Bexxar) is terribly underutillized---that there are many patients who could benefit but have not received either of these medications. Our fear is that continued underutilization may result in the pharmaceutical manufacturers taking a closer, more critical view of these agents.
Thus, Betsy and I continue to exhort lymphoma patients to obtain a consultation with a physician who is an expert in radioimmunotherapy---a radiation oncologist or a nuclear medicine physician.
Mort